Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung CancerCohen, M. H.; Justice, R.; Pazdur, R. · The Oncologist · 2009

Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Single-Institution ExperienceBinu Malhotra; Tracey Evans; Jared Weiss; Beth Eaby; Susan Stonehouse-Lee; Victoria Sherry; Corey J. Langer · 2010

Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancerComella, Pasquale; Chiuri, Vincenzo E.; De Cataldis, Giuseppe; Filippelli, Gianfranco; Maiorino, Luigi; Vessia, Giacomo; Cioffi, Riccardo; Mancarella, Sergio; Putzu, Carlo; Greco, Ettore; Palmeri, Laura; Costanzo, Raffaele; Avallone, Antonio; Franco, Luca · Lung Cancer · 2010

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung CancerSpigel, David R.; Hainsworth, John D.; Shipley, Dianna L.; Ervin, Thomas J.; Kohler, Peter C.; Lubiner, Eric T.; Peyton, James D.; Waterhouse, David M.; Burris, Howard A.; Greco, F. Anthony · Journal of Thoracic Oncology · 2012

Clinical effect of pemetrexed as the first-line treatment in Chinese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancerMa, Di; Hao, Xuezhi; Wang, Yan; Xing, Puyuan; Li, Junling · Thoracic Cancer · 2016

A review of regimens combining pemetrexed with an epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of advanced nonsquamous non-small cell lung cancerYang, James Chih-Hsin; Mok, Tony; Han, Baohui; Orlando, Mauro; Puri, Tarun; Park, Keunchil · Clinical Lung Cancer · 2017

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancerSun, Jong-Mu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue · Lung Cancer · 2010

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancerRalph G. Zinner; Frank V. Fossella; Gregory W. Gladish; Bonnie S. Glisson; George R. Blumenschein Jr.; Vassiliki A. Papadimitrakopoulou; Katherine M.W. Pisters; Edward S. Kim; Yun W. Oh; Beverly O. Peeples; Zhishen Ye; Rafael E. Curiel; Coleman K. Obasaju; Waun K. Hong; Roy S. Herbst · 2005

Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access ProgramSheeba K. Thomas; Frank V. Fossella; Diane Liu; Rainell Schaerer; Anne S. Tsao; Merrill S. Kies; Katherine M. Pisters; George R. Blumenschein Jr.; Bonnie S. Glisson; J. Jack Lee; Roy S. Herbst; Ralph G. Zinner · 2006

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumorsHai T. Tran; George R. Blumenschein; Charles Lu; Christina A. Meyers; Vali Papadimitrakopoulou; Frank V. Fossella; Ralph Zinner; Timothy Madden; Lori G. Smythe; Vinay K. Puduvalli; Reggie Munden; Mylene Truong; Roy S. Herbst · 2004

Dose Escalation of Gemcitabine Is Possible With Concurrent Chest Three-Dimensional Rather Than Two-Dimensional Radiotherapy: A Phase I Trial in Patients With Stage III Non–Small-Cell Lung CancerRalph G. Zinner; Ritsuko Komaki; James D. Cox; Bonnie S. Glisson; Katherine M.W. Pisters; Roy S. Herbst; Merril Kies; Zhongxing Liao; Waun K. Hong; Frank V. Fossella · 2009

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)Hai T. Tran; Ralph G. Zinner; George R. Blumenschein; Yun W. Oh; Vassiliki A. Papadimitrakopoulou; Edward S. Kim; Charles Lu; Mubashira Malik; Bert L. Lum; Roy S. Herbst · 2011